News

NanoCellect Biomedical Awarded $1.8M Federal Grant to Advance Imaging Flow Cytometry with Artificial Intelligence Technologies

SAN DIEGO, Calif., August 24, 2022 — (PR.com)NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced it has received a $1.8 million Phase II Small Business Innovation Research (SBIR) grant through the National Institutes of Health’s National...

August 24, 2022

Read Post

NewsJune 17, 2022

Fluent BioSciences and NanoCellect announce joint collaboration to improve resolution of single-cell RNA sequencing analysis of rare cell populations

Read Post

NewsSeptember 23, 2021

NanoCellect Biomedical Expands its Global Distribution Network to Middle East and Africa

Read Post

NewsSeptember 16, 2021

NanoCellect accelerates growth plans with close of $35 Million in Series C & D Rounds led by Vertical Venture Partners and Warburg Pincus

Read Post

NewsSeptember 9, 2021

NanoCellect Biomedical Expands its Global Distribution Network to Eastern Europe, Middle East and Africa

Read Post

NewsMay 13, 2021

NanoCellect Biomedical Reinvents the Cell Sorter with the WOLF G2

Read Post

NewsFebruary 22, 2021

NanoCellect & Cytonome/ST Reach Settlement

Read Post

News

NanoCellect Biomedical Awarded $1.8M Federal Grant to Advance Imaging Flow Cytometry with Artificial Intelligence Technologies

Fluent BioSciences and NanoCellect announce joint collaboration to improve resolution of single-cell RNA sequencing analysis of rare cell populations

NanoCellect Biomedical Expands its Global Distribution Network to Middle East and Africa

NanoCellect accelerates growth plans with close of $35 Million in Series C & D Rounds led by Vertical Venture Partners and Warburg Pincus

NanoCellect Biomedical Expands its Global Distribution Network to Eastern Europe, Middle East and Africa

NanoCellect Biomedical Reinvents the Cell Sorter with the WOLF G2

NanoCellect & Cytonome/ST Reach Settlement

Load More Posts